These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 31492715)

  • 1. Prognostic Relevance of Steroid Sulfation in Adrenocortical Carcinoma Revealed by Molecular Phenotyping Using High-Resolution Mass Spectrometry Imaging.
    Sun N; Kunzke T; Sbiera S; Kircher S; Feuchtinger A; Aichler M; Herterich S; Ronchi CL; Weigand I; Schlegel N; Waldmann J; Candida Villares Fragoso M; Whitsett TG; Gill AJ; Fassnacht M; Walch A; Kroiss M
    Clin Chem; 2019 Oct; 65(10):1276-1286. PubMed ID: 31492715
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Steroid Sulfation in Adrenal Tumors.
    Mueller JW; Vogg N; Lightning TA; Weigand I; Ronchi CL; Foster PA; Kroiss M
    J Clin Endocrinol Metab; 2021 Nov; 106(12):3385-3397. PubMed ID: 33739426
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low Protein Expression of both
    Brondani VB; Lacombe AMF; Mariani BMP; Montenegro L; Soares IC; Bezerra-Neto JE; Tanno FY; Srougi V; Chambo JL; Mendonca BB; Almeida MQ; Zerbini MCN; Fragoso MCBV
    Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33513905
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression and Prognostic Relevance of PD-1, PD-L1, and CTLA-4 Immune Checkpoints in Adrenocortical Carcinoma.
    Landwehr LS; Altieri B; Sbiera I; Remde H; Kircher S; Olabe J; Sbiera S; Kroiss M; Fassnacht M
    J Clin Endocrinol Metab; 2024 Aug; 109(9):2325-2334. PubMed ID: 38415841
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of FSCN1 and FOXM1 are associated with poor prognosis of adrenocortical carcinoma patients.
    Liang J; Liu Z; Wei X; Zhou L; Tang Y; Zhou C; Wu K; Zhang F; Zhang F; Lu Y; Zhu Y
    BMC Cancer; 2019 Nov; 19(1):1165. PubMed ID: 31783819
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Steroid metabolites for diagnosing and predicting clinicopathological features in cortisol-producing adrenocortical carcinoma.
    Suzuki S; Minamidate T; Shiga A; Ruike Y; Ishiwata K; Naito K; Ishida A; Deguchi H; Fujimoto M; Koide H; Tatsuno I; Ikeda JI; Yamazaki Y; Sasano H; Yokote K
    BMC Endocr Disord; 2020 Nov; 20(1):173. PubMed ID: 33228607
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adrenocortical cancer: mortality, hormone secretion, proliferation and urine steroids - experience from a single centre spanning three decades.
    Calissendorff J; Calissendorff F; Falhammar H
    BMC Endocr Disord; 2016 Mar; 16():15. PubMed ID: 26984275
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fascin-1 Is a Novel Prognostic Biomarker Associated With Tumor Invasiveness in Adrenocortical Carcinoma.
    Poli G; Ruggiero C; Cantini G; Canu L; Baroni G; Armignacco R; Jouinot A; Santi R; Ercolino T; Ragazzon B; Assie G; Mannelli M; Nesi G; Lalli E; Luconi M
    J Clin Endocrinol Metab; 2019 May; 104(5):1712-1724. PubMed ID: 30476173
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of FGF Receptors and Their Pathways in Adrenocortical Tumors and Possible Therapeutic Implications.
    Sbiera I; Kircher S; Altieri B; Lenz K; Hantel C; Fassnacht M; Sbiera S; Kroiss M
    Front Endocrinol (Lausanne); 2021; 12():795116. PubMed ID: 34956100
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Urine steroid metabolomics as a biomarker tool for detecting malignancy in adrenal tumors.
    Arlt W; Biehl M; Taylor AE; Hahner S; Libé R; Hughes BA; Schneider P; Smith DJ; Stiekema H; Krone N; Porfiri E; Opocher G; Bertherat J; Mantero F; Allolio B; Terzolo M; Nightingale P; Shackleton CH; Bertagna X; Fassnacht M; Stewart PM
    J Clin Endocrinol Metab; 2011 Dec; 96(12):3775-84. PubMed ID: 21917861
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adrenocortical carcinoma: clinical outcomes and prognosis of 330 patients at a tertiary care center.
    Ayala-Ramirez M; Jasim S; Feng L; Ejaz S; Deniz F; Busaidy N; Waguespack SG; Naing A; Sircar K; Wood CG; Pagliaro L; Jimenez C; Vassilopoulou-Sellin R; Habra MA
    Eur J Endocrinol; 2013 Dec; 169(6):891-899. PubMed ID: 24086089
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of the zinc-finger transcription factor Snail in adrenocortical carcinoma is associated with decreased survival.
    Waldmann J; Feldmann G; Slater EP; Langer P; Buchholz M; Ramaswamy A; Saeger W; Rothmund M; Fendrich V
    Br J Cancer; 2008 Dec; 99(11):1900-7. PubMed ID: 19018264
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Survival and prognostic factors for adrenocortical carcinoma: a single institution experience.
    Loncar Z; Djukic V; Zivaljevic V; Pekmezovic T; Diklic A; Tatic S; Dundjerovic D; Olujic B; Slijepcevic N; Paunovic I
    BMC Urol; 2015 May; 15():43. PubMed ID: 26013141
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolic reprogramming: a new relevant pathway in adult adrenocortical tumors.
    Pinheiro C; Granja S; Longatto-Filho A; Faria AM; Fragoso MC; Lovisolo SM; Lerário AM; Almeida MQ; Baltazar F; Zerbini MC
    Oncotarget; 2015 Dec; 6(42):44403-21. PubMed ID: 26587828
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeted Molecular Analysis in Adrenocortical Carcinomas: A Strategy Toward Improved Personalized Prognostication.
    Lippert J; Appenzeller S; Liang R; Sbiera S; Kircher S; Altieri B; Nanda I; Weigand I; Gehrig A; Steinhauer S; Riemens RJM; Rosenwald A; Müller CR; Kroiss M; Rost S; Fassnacht M; Ronchi CL
    J Clin Endocrinol Metab; 2018 Dec; 103(12):4511-4523. PubMed ID: 30113656
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Feminizing Adrenocortical Carcinoma: The Source of Estrogen Production and the Role of Adrenal-Gonadal Dedifferentiation.
    Wu L; Xie J; Jiang L; Su T; Ye L; Zhou W; Jiang Y; Zhang C; Ning G; Wang W
    J Clin Endocrinol Metab; 2018 Oct; 103(10):3706-3713. PubMed ID: 30053001
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Whole Body Metabolic Tumor Volume and Total Lesion Glycolysis Predict Survival in Patients with Adrenocortical Carcinoma.
    Satoh K; Patel D; Dieckmann W; Nilubol N; Kebebew E
    Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S714-20. PubMed ID: 26282908
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nomograms to Predict Recurrence-Free and Overall Survival After Curative Resection of Adrenocortical Carcinoma.
    Kim Y; Margonis GA; Prescott JD; Tran TB; Postlewait LM; Maithel SK; Wang TS; Evans DB; Hatzaras I; Shenoy R; Phay JE; Keplinger K; Fields RC; Jin LX; Weber SM; Salem AI; Sicklick JK; Gad S; Yopp AC; Mansour JC; Duh QY; Seiser N; Solorzano CC; Kiernan CM; Votanopoulos KI; Levine EA; Poultsides GA; Pawlik TM
    JAMA Surg; 2016 Apr; 151(4):365-73. PubMed ID: 26676603
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MSI2 expression in adrenocortical carcinoma: Association with unfavorable prognosis and correlation with steroid and immune-related pathways.
    Veronez LC; das Chagas PF; Corrêa CAP; Baroni M; da Silva KR; Nagano LF; Borges KS; Queiroz RGP; Tone LG; Scrideli CA
    J Cell Biochem; 2021 Dec; 122(12):1925-1935. PubMed ID: 34581457
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic significance of immunohistochemical markers in adrenocortical carcinoma.
    Zlatibor L; Paunovic I; Zivaljevic V; Dundjerovic D; Tatic S; Djukic V
    Acta Chir Belg; 2020 Feb; 120(1):23-29. PubMed ID: 30499377
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.